通过DNA甲基化介导的FGFR1沉默增强了NF-κB信号传递:对喘病原性的影响
Minglu Meng1,2, Yingjiao Ma1, Jianguo Xu3
1School of Public Health, Youjiang Medical University for Nationalities, Baise, China.
Frontiers in molecular biosciences
|October 8, 2024
概括
纤维细胞生长因子受体1 (FGFR1) 的DNA甲基化使NF-κB通路沉默,导致喘的进展. 向FGFR1甲基化为喘治疗提供了一个潜在的治疗策略.
科学领域:
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
- 遗传学 遗传学 是一个
背景情况:
- 纤维细胞生长因子受体1 (FGFR1) 涉及喘发病,但其精确的作用和调节机制尚未完全理解.
- 研究DNA甲基化在FGFR1基因表达中的作用对于理解喘发育至关重要.
研究的目的:
- 阐明通过DNA甲基化介导的FGFR1沉默影响喘中的NF-κB信号传递的机制.
- 探索针对FGFR1DNA甲基化用于喘治疗的潜力.
主要方法:
- 定量逆转录PCR (RT-qPCR) 用于测量患者血清和细胞系中的FGFR1mRNA水平.
- 细胞增殖试验 (CCK8) 和双化酶记者试验用于评估FGFR1功能和NF-κB活性.
- 使用MassARRAY的DNA甲基化分析和使用5-Aza-CdR的脱甲基化试验.
主要成果:
- 在喘患者的血清中检测到FGFR1mRNA水平升高.
- 过度表达FGFR1增强了细胞增殖和NF-κB转录活性.
- 脱甲基化DNA显著增加了FGFR1表达和NF-κB活性,在喘患者中观察到FGFR1促进剂甲基化减少.
结论:
- FGFR1的DNA甲基化使NF-κB信号通路失活,从而导致喘的进展.
- 向FGFR1DNA甲基化是一种有前途的治疗策略,用于控制喘.
更多相关视频
11:19Correlating Gene-specific DNA Methylation Changes with Expression and Transcriptional Activity of Astrocytic KCNJ10 Kir4.1
Published on: September 26, 2015
7.9K
09:52A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
Published on: December 4, 2018
7.5K
相关概念视频
NF-κB-dependent Signaling Pathway
7.3K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.3K
TGF - β Signaling Pathway
7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
Asthma: Pathogenesis and Management
363
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
363
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Co-activators and Co-repressors
7.3K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.3K
